UAB Comprehensive Cancer Center’s Fiesta Ball on May 5 will support the work of young cancer research scientists and patient and family services.
Unusual case of teen patient diagnosed with colorectal cancer receives innovative first-in-human clinical trial at UAB, reflecting a unique story of cancer and hope.
Cycliad, a community cycling event, will be held March 25 in Birmingham to benefit cancer patients at UAB.
Failure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.
March is Colorectal Cancer Awareness Month, and UAB kicks it off with an inaugural Colon on the Green event March 3.
A UAB study shows specialized treatment sites contribute to better survival rates for those with acute leukemia.
Pam Alverson, UAB'S Employee of the Month, maintains a calm, stabilizing presence in a sometimes-overwhelming arena of clinical research.
UAB Comprehensive Cancer Center holds annual ArtBLINK Gala to support high-priority and life-saving research.
UAB’s innovative Patient Care Connect Program utilizes lay navigation and provides a cost-effective new model for cancer care delivery.
The UAB Comprehensive Cancer Center has received a $16 million NCI renewal grant to advance cancer disparities research and reduce mortality rates among underserved populations.